Results 131 to 140 of about 119,703,502 (227)

Potential risk of neoplasms with fezolinetant: clinical evidence, mechanisms, and post-marketing implications. [PDF]

J Endocr Soc
Boretti E, Dogné JM, Douxfils J.
europepmc   +1 more source

Delayed and long-delayed chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a scoping review of reporting gaps. [PDF]

ESMO Open
Iimura Y, Chow R, Watanabe D, Hayashi T, Kuroda S, Jordan K, Ruhlmann CH, Molassiotis A, Affronti ML, Scotté F, Iihara H, MASCC Antiemetic Study Group.   +11 more
europepmc   +1 more source

Netupitant versus aprepitant: model-predicted neurokinin-1 receptor occupancy and implications for long-delayed nausea and vomiting prevention. [PDF]

Support Care Cancer
Iihara H, Bianchini G, Aapro M, Licata L, Bernareggi A, Navari RM, Park YH, Jordan K, Vidal M, Scotté F, Roeland EJ, Schwartzberg L, Rugo HS.   +12 more
europepmc   +1 more source

A brain-first framework for perimenopause management: the case for non-invasive neuromodulation. [PDF]

Front Glob Womens Health
Radytė E, Karvelyte I.
europepmc   +1 more source

Olanzapine Use and Vomiting Incidence in Chemotherapy-receiving Patients With Cervical Cancer: Multicenter Post Hoc Analysis. [PDF]

In Vivo
Kawamura Y, Yoshida K, Morita H, Nakai M, Matsumoto T, Gohara Y, Hoshino N, Tonomura N, Banba M, Yamaguchi A, Tachibana M, Fukushima T, Hosokawa H, Mura T, Yabuki T, Watanabe S, Watanabe A, Sugiura M.   +17 more
europepmc   +1 more source

Duloxetine ameliorates acute pancreatitis-associated inflammation and modulates pain related neuroinflammatory pathways via modulation of SP-related neurokinin signaling and PAR2/TRPV1 pathways. [PDF]

Front Toxicol
Almutary KH, Elsheakh AR, Nader MA, Zaghloul MS.   +3 more
europepmc   +1 more source

The C-terminal truncated splicing variant of NK1R negatively modulates substance P-stimulated NK1R signaling. [PDF]

FEBS Open Bio
Nguyen LP, Nguyen DT, Cho M, Kim J, In S, Nguyen TU, Hurh S, Park BJ, Hwang JI.   +8 more
europepmc   +1 more source

Efficacy and safety of GS1-144, a novel neurokinin 3 receptor antagonist, for moderate-to-severe vasomotor symptoms associated with menopause in Chinese women: a randomized, double-blind, placebo-controlled phase 2 trial. [PDF]

Menopause
Wang Y, Wang X, Wang W, Lin J, He Y, Chen H, Shou H, Ai X, Zhang Q, Cai Y, Wu Y, Guo R, Hu L, Chen H, Xiang W, Pan C, Yu Q.   +16 more
europepmc   +1 more source

Opioid Peptide Hybrids as Multifunctional Analgesic Ligands: Emphasis on Intracellular Signaling. [PDF]

Pharmaceuticals (Basel)
Cecherz I, Waśkiewicz J, Dudek A, Polatyński D, Wtorek K, Piekielna-Ciesielska J.   +5 more
europepmc   +1 more source

Effects of chrysin on Kisspeptin, neurokinin B, and dynorphin neurons and <i>gonadotropin-releasing hormone</i> gene expression in stress-induced rats: An experimental study. [PDF]

Int J Reprod Biomed
Haghighat K, Mahmoudi F, Khazali H.
europepmc   +1 more source